Annual Cash & Cash Equivalents
$410.89M$256.45M-38.43%
Summary
- Current Value
- As of today, EVO annual cash & cash equivalents is $410.89M, down -38.43% on
- Historical Performance
- EVO annual cash & cash equivalents is down -57.90% over the past 3 years, and up +14.38% over the past 5 years
- All-Time High Comparison
- EVO annual cash & cash equivalents is currently -57.90% below its historical high of $975.98M set on
- 3-Year Low Comparison
- EVO annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- EVO annual cash & cash equivalents is higher than 86.86% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $410.89M | -38.4% | -57.9% | +14.4% | +390.7% | |
| Quarterly Cash & Cash Equivalents | $278.79M | -17.6% | -65.5% | -6.9% | +192.6% | |
| Price | $3.68 | -14.6% | -57.2% | -79.7% | +81.7% | |
| Annual Current Assets | $706.17M | -29.2% | -43.6% | +34.0% | +613.8% | |
| Annual Total Liabilities | $1.08B | -17.0% | +5.8% | +28.1% | +2046.2% | |
| Annual Working Capital | $349.36M | -27.9% | -60.4% | +7.1% | +472.8% | |
| Annual Net Income | -$212.10M | -133.8% | -183.3% | -609.0% | -235.3% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $766.81M | N/A | -46.4% |
| 5Y | $975.98M | -57.9% | |
| All | $975.98M | -57.9% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $410.89M | at low | |
| 5Y | $410.89M | at low | |
| All | $3.33M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of EVO?
As of today, EVO annual cash & cash equivalents is $410.89M
What is 1-year change in EVO annual cash & cash equivalents?
EVO annual cash & cash equivalents is down -38.43% year-over-year
What is 3-year change in EVO annual cash & cash equivalents?
EVO annual cash & cash equivalents is down -57.90% over the past 3 years
How far is EVO annual cash & cash equivalents from its all-time high?
EVO annual cash & cash equivalents is currently -57.90% below its historical high of $975.98M set on December 31, 2021
How does EVO annual cash & cash equivalents rank versus sector peers?
EVO annual cash & cash equivalents is higher than 86.86% of companies in Healthcare sector
When is EVO next annual earnings release?
As of today, the next annual earnings release for EVO has not been scheduled
Quarterly Cash & Cash Equivalents
$278.79M$129.71M-31.75%
Summary
- Current Value
- As of today, EVO quarterly cash & cash equivalents is $278.79M, down -31.75% on
- Historical Performance
- EVO quarterly cash & cash equivalents is down -17.63% year-over-year, and down -65.45% over the past 3 years
- All-Time High Comparison
- EVO quarterly cash & cash equivalents is currently -71.43% below its historical high of $975.98M set on
- 3-Year Low Comparison
- EVO quarterly cash & cash equivalents is at its 3-year low
- Sector Comparison
- EVO quarterly cash & cash equivalents is higher than 75.77% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $278.79M | -31.8% | -17.6% | -65.5% | -6.9% | |
| Annual Cash & Cash Equivalents | $410.89M | – | -38.4% | -57.9% | +14.4% | |
| Price | $3.68 | -6.6% | -14.6% | -57.2% | -79.7% | |
| Quarterly Current Assets | $931.91M | +31.3% | +19.6% | -13.2% | +86.0% | |
| Quarterly Total Liabilities | $1.14B | +1.1% | +0.2% | +12.8% | +39.8% | |
| Quarterly Working Capital | $491.91M | +89.4% | +20.9% | -33.5% | +80.6% | |
| Quarterly Net Income | -$50.35M | -2.1% | -15.6% | -5.8% | -2955.2% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $410.89M | N/A | -32.1% |
| 3Y | $766.81M | N/A | -63.6% |
| 5Y | $975.98M | -71.4% | |
| All | $975.98M | -71.4% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $278.79M | at low | |
| 3Y | $278.79M | at low | |
| 5Y | $278.79M | at low | |
| All | $14.76M | +1788.5% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of EVO?
As of today, EVO quarterly cash & cash equivalents is $278.79M
What is EVO quarterly cash & cash equivalents most recent change?
EVO quarterly cash & cash equivalents was down -31.75% on September 1, 2025
What is 1-year change in EVO quarterly cash & cash equivalents?
EVO quarterly cash & cash equivalents is down -17.63% year-over-year
How far is EVO quarterly cash & cash equivalents from its all-time high?
EVO quarterly cash & cash equivalents is currently -71.43% below its historical high of $975.98M set on December 31, 2021
How does EVO quarterly cash & cash equivalents rank versus sector peers?
EVO quarterly cash & cash equivalents is higher than 75.77% of companies in Healthcare sector
When is EVO next earnings release?
As of today, the next earnings release for EVO has not been scheduled
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- EVO Official Website www.evotec.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1412558/000110465925035638/0001104659-25-035638-index.htm
- EVO Profile on Yahoo Finance finance.yahoo.com/quote/EVO
- EVO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/evo